Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. (Q39693956)

14 September 2017

Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. (English)

1 reference

14 September 2017

1

1 reference

14 September 2017

Ignacio García-Bolao

2

1 reference

14 September 2017

Amaia Zudaire

3

1 reference

14 September 2017

Alfonso Macías

4

1 reference

14 September 2017

Juan J Gavira

5

1 reference

14 September 2017

Javier Beaumont

6

1 reference

14 September 2017

Teresa Arias

7

1 reference

14 September 2017

Ana Huerta

8

1 reference

14 September 2017

Javier Díez

9

1 reference

14 September 2017

11 June 2010

1 reference

14 September 2017

Cardiovascular Research

1 reference

14 September 2017

88

1 reference

14 September 2017

2

1 reference

14 September 2017

304-313

1 reference

The effect of cardiac resynchronization on morbidity and mortality in heart failure

14 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Predictors of lack of response to resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Effects of cardiac resynchronization therapy on disease progression in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Annexins and Ca2+ handling in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Myocyte apoptosis during acute myocardial infarction in rats is related to early sarcolemmal translocation of annexin A5 in border zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Protein kinase C targeting in antineoplastic treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Bcl-2 Phosphorylation by p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Apoptosis and necrosis induced by cyclic mechanical stretching in alveolar type II cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Annexin-mediated Ca2+ influx regulates growth plate chondrocyte maturation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Association of annexin A5 with Na+/Ca2+ exchanger and caveolin-3 in non-failing and failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Energy metabolism in heart failure and remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Heart mitochondria: gates of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ183

21 January 2018

Identifiers

DOI

10.1093/CVR/CVQ183

1 reference

14 September 2017

1 reference